1. Home
  2. TBBK vs VCYT Comparison

TBBK vs VCYT Comparison

Compare TBBK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

HOLD

Current Price

$53.55

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$32.13

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBBK
VCYT
Founded
1999
2006
Country
United States
United States
Employees
733
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.8B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
TBBK
VCYT
Price
$53.55
$32.13
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$69.00
$45.13
AVG Volume (30 Days)
477.7K
794.2K
Earning Date
04-30-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
14.69
164.52
EPS
4.92
0.82
Revenue
$141,147,000.00
N/A
Revenue This Year
N/A
$13.33
Revenue Next Year
$11.90
$12.53
P/E Ratio
$10.82
$37.71
Revenue Growth
20.85
N/A
52 Week Low
$40.51
$22.61
52 Week High
$81.65
$50.71

Technical Indicators

Market Signals
Indicator
TBBK
VCYT
Relative Strength Index (RSI) 40.01 36.04
Support Level $49.11 $25.95
Resistance Level $53.83 $32.79
Average True Range (ATR) 2.28 1.47
MACD 0.18 -0.28
Stochastic Oscillator 38.54 15.82

Price Performance

Historical Comparison
TBBK
VCYT

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: